Phibro Animal Health Corp’s recently made public that its 10% Owner BFI Co., LLC acquired Company’s shares for reported $5.79 million on May 19 ’25. In the deal valued at $24.00 per share,241,129 shares were bought.
Then, CORCORAN E THOMAS bought 5,000 shares, generating $110,500 in total proceeds. Upon buying the shares at $22.10, the Director now owns 30,000 shares.
Before that, BFI Co., LLC bought 247,769 shares. Phibro Animal Health Corp shares valued at $6,385,007 were divested by the 10% Owner at a price of $25.77 per share.
JP Morgan upgraded its Phibro Animal Health Corp [PAHC] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including BNP Paribas Exane’s analysts, who increased its forecast for the stock in mid June from “an Underperform” to “a Neutral”. JP Morgan began covering PAHC with “Neutral” recommendation on September 10, 2024. Exane BNP Paribas started covering the stock on December 07, 2023. It rated PAHC as “an Underperform”.
Price Performance Review of PAHC
On Monday, Phibro Animal Health Corp [NASDAQ:PAHC] saw its stock jump 6.79% to $29.9. Over the last five days, the stock has gained 16.52%. Phibro Animal Health Corp shares have risen nearly 79.04% since the year began. Nevertheless, the stocks have risen 42.38% over the past one year. While a 52-week high of $28.49 was reached on 07/07/25, a 52-week low of $16.16 was recorded on 04/21/25.
Levels Of Support And Resistance For PAHC Stock
The 24-hour chart illustrates a support level at 29.11, which if violated will result in even more drops to 28.33. On the upside, there is a resistance level at 30.64. A further resistance level may holdings at 31.38.
How much short interest is there in Phibro Animal Health Corp?
A steep rise in short interest was recorded in Phibro Animal Health Corp stocks on 2025-06-13, growing by 54551.0 shares to a total of 0.99 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.94 million shares. There was a rise of 5.5%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 21, 2022 when ROTH Capital began covering the stock and recommended ‘”a Buy”‘ rating along with a $18 price target.
